Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Parasitic Diseases » Protozoan Infections » Euglenozoa Infections » Leishmaniasis
Diseases [C] » Infections [C01] » Parasitic Diseases » Skin Diseases, Parasitic » Leishmaniasis
Diseases [C] » Infections [C01] » Vector Borne Diseases » Leishmaniasis
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Infectious » Skin Diseases, Parasitic » Leishmaniasis
Description
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). MeSH
Hierarchy View
Subtype Terms (2)
Leishmaniasis, Cutaneous
31 drugs (14 approved, 17 experimental)
Leishmaniasis, Visceral
21 drugs (10 approved, 11 experimental)
Approved Indicated Drugs (2)
Phase 1 Indicated Drugs (5)
Organization Involved with Phase 4 Indications (24)
Centro Internacional de Entrenamiento e Investigaciones Médicas
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Organization Involved with Phase 3 Indications (53)
Amhara Regional Health Bureau, Amhara Region
Bharat Serums and Vaccines Limited
Cardiovascular Foundation of Colombia
Federal University of Mato Grosso do Sul
Fundación Cardiovascular de Colombia
Fundacion Nacional de Dermatologia
Institute of Endemic Diseases, Sudan
Institute of Tropical Medicine, Belgium
Instituto Conmemorativo Gorgas de Estudios de la Salud
Instituto de Medicina Integral Professor Fernando Figueira
Instituto Nacional de Infectologia, Brazil
Kenya Medical Research Institute
Kerman University of Medical Sciences
Leishmania East Africa Platform
Mashad University of Medical Sciences
Organization Involved with Phase 2 Indications (29)
AB Foundation for Medical Research
Bill and Melinda Gates Foundation
Centro de Investigaciones Bioclínicas de la Fundación Fader
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
